Research Article

The benefits of biochemical bone markers

Sek Aksaranugraha*

Published: 05/04/2020 | Volume 3 - Issue 1 | Pages: 027-031

To improve efficiency in Osteoporosis treatment
To adjust the dosage of medication for osteoporosis with BMK
To adjust bone life cycle as needed
To prevent bone necrosis which dentists have been worried.
To reduce cost of treatment

Read Full Article HTML DOI: 10.29328/journal.ijbmr.1001013 Cite this Article


  1. Bernardi D, Zaninotto M, Plebani M. Requirements for improving quality in the measurement of bone markers. Clin Chim Acta. 2004; 346; 79-86. PubMed:
  2. Bunyaratavej N, Kitimanon N, Boonthitikul S. Study of the level of biochemical bone markers: NMID osteocalcin and bone resorptive marker (beta CTx) in Thai women. J Med Assoc Thai. 2001; 84 Suppl 2: S560-565. PubMed:
  3. Bunyaratavej N, Kittimanon N. Study of procollagen type 1 nitrogenous propeptides (PINP) in reproductive female. J Med Assoc Thai. 2005; 88 Suppl 5: S27-28. PubMed:
  4. Aksaranugraha S. Observation: Application and Advantages of BMK in OP by Monitoring the Dose of Antiresorption Drugs with CTx. J Med Assoc Thai. 2011; 94 Suppl 5: S65-66. PubMed:
  5. Aksaranugraha S.BMD Changes following 2 year treatment of Osteoporosis by using BMK to monitor the dose of Bisphosphonates. J Med Assoc Thai. 2015; 98 Suppl 8: S8-S12. PubMed: